MedPath

Open study of SGP2 for myopia and myopic astigmatism

Not Applicable
Conditions
Myopia and myopic astigmatism
Registration Number
JPRN-UMIN000038182
Lead Sponsor
ROHTO pharmaceutical CO.,LTD
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patient who have the following eye symptoms in one or both eyes. - Acute or subacute inflammation of the anterior segment - Eye infection - Uveitis - Eyelid abnormalities

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety(13 weeks after first day the subect used)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath